Literature DB >> 29802438

[Systemic effects of amide-linked local anesthetics : Old drugs, new magic bullets?]

T Piegeler1, R Werdehausen2.   

Abstract

Besides the well-known analgesic effects of amide-linked local anesthetics exerted via the inhibition of the voltage-gated sodium channel, these substances also possess a certain number of properties, which bear the potential to positively influence the outcome after surgery. The results of several experimental as well as clinical studies suggest the possibility of an enhanced recovery after surgery, reduction in the incidence of chronic pain, preservation of endothelial barrier function during acute lung injury and the prevention of metastasis of solid tumors by systemic effects of local anesthetic administration. Mechanistic studies were able to identify several "new targets", such as the inhibition of spinal glycine transporters or of inflammatory signaling as induced by tumor necrosis factor alpha. Further elucidation of these mechanistic pathways as well as the translation of these promising experimental results into clinical practice is a crucial component of research activities in the field of anesthesia.

Entities:  

Keywords:  Anesthetics, local; Inflammation; Neoplasms; Pain; Treatment outcome

Mesh:

Substances:

Year:  2018        PMID: 29802438     DOI: 10.1007/s00101-018-0453-2

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  42 in total

1.  Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary cytoreductive surgery.

Authors:  Gildasio S de Oliveira; Shireen Ahmad; Julian C Schink; Diljeet K Singh; Paul C Fitzgerald; Robert J McCarthy
Journal:  Reg Anesth Pain Med       Date:  2011 May-Jun       Impact factor: 6.288

Review 2.  Regulation of transendothelial permeability by Src kinase.

Authors:  Guochang Hu; Richard D Minshall
Journal:  Microvasc Res       Date:  2008-10-28       Impact factor: 3.514

3.  Potent inhibition by ropivacaine of metastatic colon cancer SW620 cell invasion and NaV1.5 channel function.

Authors:  D T Baptista-Hon; F M Robertson; G B Robertson; S J Owen; G W Rogers; E L Lydon; N H Lee; T G Hales
Journal:  Br J Anaesth       Date:  2014-05-22       Impact factor: 9.166

4.  Clinically relevant concentrations of lidocaine and ropivacaine inhibit TNFα-induced invasion of lung adenocarcinoma cells in vitro by blocking the activation of Akt and focal adhesion kinase.

Authors:  T Piegeler; M Schläpfer; R O Dull; D E Schwartz; A Borgeat; R D Minshall; B Beck-Schimmer
Journal:  Br J Anaesth       Date:  2015-11       Impact factor: 9.166

5.  Lidocaine metabolites inhibit glycine transporter 1: a novel mechanism for the analgesic action of systemic lidocaine?

Authors:  Robert Werdehausen; David Kremer; Timo Brandenburger; Lukas Schlösser; Janusz Jadasz; Patrick Küry; Inge Bauer; Carmen Aragón; Volker Eulenburg; Henning Hermanns
Journal:  Anesthesiology       Date:  2012-01       Impact factor: 7.892

Review 6.  Anaesthetic techniques for risk of malignant tumour recurrence.

Authors:  Ozlem S Cakmakkaya; Kerstin Kolodzie; Christian C Apfel; Nathan Leon Pace
Journal:  Cochrane Database Syst Rev       Date:  2014-11-07

7.  Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis?

Authors:  Aristomenis K Exadaktylos; Donal J Buggy; Denis C Moriarty; Edward Mascha; Daniel I Sessler
Journal:  Anesthesiology       Date:  2006-10       Impact factor: 7.892

8.  Src phosphorylation of endothelial cell surface intercellular adhesion molecule-1 mediates neutrophil adhesion and contributes to the mechanism of lung inflammation.

Authors:  Guoquan Liu; Stephen M Vogel; Xiaopei Gao; Kamran Javaid; Guochang Hu; Sergei M Danilov; Asrar B Malik; Richard D Minshall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-04-07       Impact factor: 8.311

9.  Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.

Authors:  Susanne Herroeder; Sabine Pecher; Marianne E Schönherr; Grit Kaulitz; Klaus Hahnenkamp; Helmut Friess; Bernd W Böttiger; Harry Bauer; Marcel G W Dijkgraaf; Omarcel G W Dijkgraaf; Marcel E Durieux; Markus W Hollmann
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

10.  Lidocaine and ropivacaine, but not bupivacaine, demethylate deoxyribonucleic acid in breast cancer cells in vitro.

Authors:  P Lirk; M W Hollmann; M Fleischer; N C Weber; H Fiegl
Journal:  Br J Anaesth       Date:  2014-06-19       Impact factor: 9.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.